... This agreement enables TNIB to focus on the development and commercialization of therapeutic treatments for cancer, HIV/AIDS and autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system. ...
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130911005267&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130911005267&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment